Course Overview

The details of Brexit are not yet known but companies need to plan for the potential changes. Attend this NSF workshop with industry peers to explore the potential scenarios and develop a contingency plan for your company. This is not a ‘one off’ workshop but a continuing program of engagement as the details of BREXIT emerge over the next months or years.

  1. Do you manufacture medicinal products in the UK or EU for sale in the EU or UK?

  1. Do you supply active pharmaceutical ingredients used in medicinal products placed on the market in the UK or EU?

  1. Do you know what will need to change due to Brexit?

If you answer ‘YES’ to 1 or 2 and ‘NO’ to 3 you need to attend this NSF Brexit Workshop – Are you Ready?

Why You Should Attend

  • The UK is a manufacturer of many products which are sold in the EU
  • The UK is the second largest pharmaceutical medicinal product market in Europe
    • Companies need to understand the impact of selling product in the UK and exporting to the EU post-Brexit
  • There is lots of uncertainty surrounding Brexit.  However, it is inevitably going to have an impact on:
    • Companies manufacturing in the UK
    • Companies selling product in the UK

Who Would Benefit

  • Heads of quality of companies manufacturing/supplying medicinal products to the UK/EU
  • Heads of quality/supply chain supplying active pharmaceutical ingredients into the EU/UK
  • Anyone appointed by their company as Brexit project lead

By The End of This Workshop, You Will…

  • Have an understanding of the potential implications of Brexit
  • Have a peer developed tool which can be used within your own company to help develop a Brexit contingency plan
  • Have engaged with experts in EU regulations and know how to manage changes linked to Brexit
  • Become part of a network receiving updates as the implementation processes around Brexit develop, as related to pharmaceutical QA
  • Receive a copy of the potential risks/contingency plans each company should develop to manage the Brexit process


You will receive:

  • A copy of material used at the workshop
  • A tool which you can use ‘in-house’ to develop a company level Brexit contingency plan
  • Invitations to follow-up webinars relating to Brexit
  • Updates relating to Brexit as more is known moving forward

Facilitated By

The workshop will be facilitated by Lynne Byers and Peter Gough.

Lynne has extensive pharmaceutical manufacturing management and QA experience gained over 35 years working for three major international companies. In addition she has worked as the Head of Inspectorate and Licensing for the MHRA. Lynne has an excellent understanding of the EU GMP regulations and has broad experience with the manufacture of a wide range of parenteral and non-parenteral dosage forms.

Peter has over 40 years’ experience in the pharmaceutical industry and for the past 15 years has been responsible for advising senior management regarding changes to pharmaceutical legislation and guidance.

Workshop Cost:

Single/1st Delegate Booking - £850.00 (Excl VAT)

2nd Delegate Booking - 20% Discount


Please use code ‘WK2017’ when you contact us to benefit from the discount. Offer cannot be used in conjunction with any other offer or discount. Offer can only be redeemed against one booking – use by 30 November 2017.